UCB has acquired Lectus Therapeutics's key pharmaceutical assets today via a licence and acquisition agreement.
134956
UCB : acquires Lectus Therapeutics'' key pharmaceutical assets
115768
Xilinx acquires PetaLogix
96357
Bausch + Lomb to acquire ISTA Pharmaceuticals
32474
GlaxoSmithKline to acquire Sirtris Pharmaceuticals
160882
CNH Global NV acquires full ownership of L&T --
9174
Mylan acquires generic injectables unit from Strides Arcolab
128654
MDRNA buys DNA technology from Valeant Pharmaceuticals for undisclosed amount
28286
DuPont successfully completes tender offer for
159678
Aeolus Pharmaceuticals completes $1.5 million financing
88218
ULURU Inc. announces extensive strategic relationship with Melmed Holding AG.
28320
Incyte enters into collaboration and license agreement with Novartis
108950
Ubisoft acquires Massive Entertainment
7892
Conifex solidifies purchase agreements
12489
DuPont acquires full ownership of Solae
92886
Commission approves acquisition of banking assets by Banco Santander
108775
Pharmaceutical company sealed
154017
ABB completes acquisition of Thomas & Betts